Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-04

Clinical Trial Update: Topical Cetirizine 1% vs Minoxidil 5% Gel in Treatment of Androgenetic Alopecia [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing topical cetirizine 1% with minoxidil 5% gel for androgenetic alopecia is ongoing or not yet updated in status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • cetirizine 1% (cetirizine)
  • minoxidil 5% gel (minoxidil)

Snippet

Sponsor: Assiut University | Conditions: Androgenetic Alopecia | Phase 4 | Status: UNKNOWN